Literature DB >> 27753532

Histone chaperone ASF1B promotes human β-cell proliferation via recruitment of histone H3.3.

Pradyut K Paul1, Mary E Rabaglia1, Chen-Yu Wang1, Donald S Stapleton1, Ning Leng2, Christina Kendziorski3, Peter W Lewis4, Mark P Keller1, Alan D Attie1.   

Abstract

Anti-silencing function 1 (ASF1) is a histone H3-H4 chaperone involved in DNA replication and repair, and transcriptional regulation. Here, we identify ASF1B, the mammalian paralog to ASF1, as a proliferation-inducing histone chaperone in human β-cells. Overexpression of ASF1B led to distinct transcriptional signatures consistent with increased cellular proliferation and reduced cellular death. Using multiple methods of monitoring proliferation and mitotic progression, we show that overexpression of ASF1B is sufficient to induce human β-cell proliferation. Co-expression of histone H3.3 further augmented β-cell proliferation, whereas suppression of endogenous H3.3 attenuated the stimulatory effect of ASF1B. Using the histone binding-deficient mutant of ASF1B (V94R), we show that histone binding to ASF1B is required for the induction of β-cell proliferation. In contrast to H3.3, overexpression of histone H3 variants H3.1 and H3.2 did not have an impact on ASF1B-mediated induction of proliferation. Our findings reveal a novel role of ASF1B in human β-cell replication and show that ASF1B and histone H3.3A synergistically stimulate human β-cell proliferation.

Entities:  

Keywords:  ASF1B; cell cycle; histone H3.3; replication-independent histone deposition; β-cell proliferation

Mesh:

Substances:

Year:  2016        PMID: 27753532      PMCID: PMC5176155          DOI: 10.1080/15384101.2016.1241914

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  70 in total

1.  Yeast ASF1 protein is required for cell cycle regulation of histone gene transcription.

Authors:  A Sutton; J Bucaria; M A Osley; R Sternglanz
Journal:  Genetics       Date:  2001-06       Impact factor: 4.562

Review 2.  Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy.

Authors:  D B Cornelio; R Roesler; G Schwartsmann
Journal:  Ann Oncol       Date:  2007-03-09       Impact factor: 32.976

3.  A model-based analysis to infer the functional content of a gene list.

Authors:  Michael A Newton; Qiuling He; Christina Kendziorski
Journal:  Stat Appl Genet Mol Biol       Date:  2012-01-06

4.  Stimulation of human and rat islet beta-cell proliferation with retention of function by the homeodomain transcription factor Nkx6.1.

Authors:  Jonathan C Schisler; Patrick T Fueger; Daniella A Babu; Hans E Hohmeier; Jeffery S Tessem; Danhong Lu; Thomas C Becker; Bashoo Naziruddin; Marlon Levy; Raghavendra G Mirmira; Christopher B Newgard
Journal:  Mol Cell Biol       Date:  2008-03-17       Impact factor: 4.272

5.  Chromatin assembly factor-1, a marker of clinical value to distinguish quiescent from proliferating cells.

Authors:  Sophie E Polo; Stamatios E Theocharis; Jerzy Klijanienko; Alexia Savignoni; Bernard Asselain; Philippe Vielh; Geneviève Almouzni
Journal:  Cancer Res       Date:  2004-04-01       Impact factor: 12.701

6.  The circadian clock component BMAL1 is a critical regulator of p21WAF1/CIP1 expression and hepatocyte proliferation.

Authors:  Aline Gréchez-Cassiau; Béatrice Rayet; Fabienne Guillaumond; Michèle Teboul; Franck Delaunay
Journal:  J Biol Chem       Date:  2007-12-17       Impact factor: 5.157

7.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome.

Authors:  Bo Li; Colin N Dewey
Journal:  BMC Bioinformatics       Date:  2011-08-04       Impact factor: 3.307

8.  CAF-1 is essential for heterochromatin organization in pluripotent embryonic cells.

Authors:  Martin Houlard; Soizik Berlivet; Aline V Probst; Jean-Pierre Quivy; Patrick Héry; Geneviève Almouzni; Matthieu Gérard
Journal:  PLoS Genet       Date:  2006-09-11       Impact factor: 5.917

9.  Dissecting the roles of the histone chaperones reveals the evolutionary conserved mechanism of transcription-coupled deposition of H3.3.

Authors:  Yunkyoung Song; Ja-Hwan Seol; Jae-Hyun Yang; Hye-Jin Kim; Jeung-Whan Han; Hong-Duk Youn; Eun-Jung Cho
Journal:  Nucleic Acids Res       Date:  2013-04-05       Impact factor: 16.971

Review 10.  Human β-cell proliferation and intracellular signaling part 2: still driving in the dark without a road map.

Authors:  Ernesto Bernal-Mizrachi; Rohit N Kulkarni; Donald K Scott; Franck Mauvais-Jarvis; Andrew F Stewart; Adolfo Garcia-Ocaña
Journal:  Diabetes       Date:  2014-03       Impact factor: 9.461

View more
  19 in total

1.  Light of DNA-alkylating agents in castration-resistant prostate cancer cells: a novel mixed EGFR/DNA targeting combi-molecule.

Authors:  Guan-Can Liang; Hao-Feng Zheng; Yan-Xiong Chen; Teng-Cheng Li; Wei Liu; You-Qiang Fang
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

2.  LncRNA XIST serves as a ceRNA to regulate the expression of ASF1A, BRWD1M, and PFKFB2 in kidney transplant acute kidney injury via sponging hsa-miR-212-3p and hsa-miR-122-5p.

Authors:  Qian Cheng; Lin Wang
Journal:  Cell Cycle       Date:  2020-01-08       Impact factor: 4.534

3.  Identification of direct transcriptional targets of NFATC2 that promote β cell proliferation.

Authors:  Shane P Simonett; Sunyoung Shin; Jacob A Herring; Rhonda Bacher; Linsin A Smith; Chenyang Dong; Mary E Rabaglia; Donnie S Stapleton; Kathryn L Schueler; Jeea Choi; Matthew N Bernstein; Daniel R Turkewitz; Carlos Perez-Cervantes; Jason Spaeth; Roland Stein; Jeffery S Tessem; Christina Kendziorski; Sündüz Keleş; Ivan P Moskowitz; Mark P Keller; Alan D Attie
Journal:  J Clin Invest       Date:  2021-11-01       Impact factor: 14.808

4.  miR-24-3p Regulates Epithelial-Mesenchymal Transition and the Malignant Phenotype of Pancreatic Adenocarcinoma by Regulating ASF1B Expression.

Authors:  Wentao Huang; Tiansheng Lin; Long Huang; Junyi Wu; Jiaming Hong; Funan Qiu; Yifeng Tian; Yaodong Wang
Journal:  Biochem Genet       Date:  2022-09-17       Impact factor: 2.220

5.  Increased ASF1B Expression Correlates With Poor Prognosis in Patients With Gliomas.

Authors:  Huaxin Zhu; Hengyang Ouyang; Xinyi Pan; Zhixiong Zhang; Jiacong Tan; Nianzu Yu; Meihua Li; Yeyu Zhao
Journal:  Front Oncol       Date:  2022-07-06       Impact factor: 5.738

6.  Two Novel Candidate Genes for Insulin Secretion Identified by Comparative Genomics of Multiple Backcross Mouse Populations.

Authors:  Tanja Schallschmidt; Sandra Lebek; Delsi Altenhofen; Mareike Damen; Yvonne Schulte; Birgit Knebel; Ralf Herwig; Axel Rasche; Torben Stermann; Anne Kamitz; Nicole Hallahan; Markus Jähnert; Heike Vogel; Annette Schürmann; Alexandra Chadt; Hadi Al-Hasani
Journal:  Genetics       Date:  2018-10-19       Impact factor: 4.562

7.  ASF1B chaperones histone 3.3 to the β-cell cycle dance.

Authors:  Ronadip R Banerjee; Sushant Bhatnagar
Journal:  Cell Cycle       Date:  2016-11-18       Impact factor: 4.534

8.  Tangshen Formula Treatment for Diabetic Kidney Disease by Inhibiting Racgap1-stata5-Mediated Cell Proliferation and Restoring miR-669j-Arntl-Related Circadian Rhythm.

Authors:  Xiuying Wang; Hai Zhao; Xingquan Wu; Guangsheng Xi; Shengxue Zhou
Journal:  Med Sci Monit       Date:  2018-11-05

9.  LINC00665 Promotes the Progression of Multiple Myeloma by Adsorbing miR-214-3p and Positively Regulating the Expression of PSMD10 and ASF1B.

Authors:  Chong Wang; Mengya Li; Shujuan Wang; Zhongxing Jiang; Yanfang Liu
Journal:  Onco Targets Ther       Date:  2020-07-07       Impact factor: 4.147

10.  ASF1B promotes cervical cancer progression through stabilization of CDK9.

Authors:  Xinjian Liu; Jingwei Song; Yenan Zhang; Huiquan Wang; Hongzhi Sun; Xiaomin Feng; Min Hou; Guo Chen; Qi Tang; Minjun Ji
Journal:  Cell Death Dis       Date:  2020-08-26       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.